Droprenilamine

This classification denotes a vasodilating agent with the molecular formula C24H33N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 31IPX0ZD7R, chemically known as (+-)-n-(3,3-diphenylpropyl)-alpha-methylcyclohexaneethylamine but generally known as droprenilamine, which bears US NIH Compound Identifier 65470. European Medicines Agency schedules Droprenilamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06411MIG. The term DROPRENILAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). DROPRENILAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule droprenilamine under HS 29214980 and SITC 51454. As of Q4 2014, DROPRENILAMINE remains the US FDA Preferred Term for this commodity. Droprenilamine bears US NLM identifiers UMLS ID C1880414 and NCI Concept Code C65488. SMILES: N(C(CC1CCCCC1)C)CCC(c1ccccc1)c1ccccc1.